These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 19299379

  • 1. Balancing the risks and benefits of prolonged use of infliximab.
    Schölmerich J.
    Gut; 2009 Apr; 58(4):477-8. PubMed ID: 19299379
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T, Al Kahtani K, Bakshi N, Abouzied ME, Helmy A.
    Trop Gastroenterol; 2010 Apr; 31(1):51-3. PubMed ID: 20860231
    [No Abstract] [Full Text] [Related]

  • 5. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV.
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract] [Full Text] [Related]

  • 6. Mucormycosis in a Crohn's disease patient treated with infliximab.
    Wall GC, Leman BI.
    Digestion; 2009 Jul; 80(3):182-4. PubMed ID: 19776582
    [Abstract] [Full Text] [Related]

  • 7. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
    Joosten AA, van Olffen GH, Hageman G.
    Ned Tijdschr Geneeskd; 2003 Jul 26; 147(30):1470-2. PubMed ID: 12908351
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis and treatment with infliximab.
    Zhang Z, Correa H, Bégué RE.
    N Engl J Med; 2002 Feb 21; 346(8):623-6. PubMed ID: 11859880
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [What can be expected from biological therapies for Crohn's disease?].
    Lemann M.
    Gastroenterol Clin Biol; 2001 Nov 21; 25(11):945-7. PubMed ID: 11845043
    [No Abstract] [Full Text] [Related]

  • 11. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalù AB.
    Recenti Prog Med; 2006 Feb 21; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [Abstract] [Full Text] [Related]

  • 12. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
    MMW Fortschr Med; 2008 Dec 11; 150(51-52):54-5. PubMed ID: 19156959
    [No Abstract] [Full Text] [Related]

  • 13. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M, Melliez H, Seguy D, Viget N, Cortot A, Colombel JF.
    Inflamm Bowel Dis; 2005 Jun 11; 11(6):618-20. PubMed ID: 15905713
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reactivation tuberculosis in a patient with anti-TNF-alpha treatment.
    Núñez Martínez O, Ripoll Noiseux C, Carneros Martín JA, González Lara V, Gregorio Marañón HG.
    Am J Gastroenterol; 2001 May 11; 96(5):1665-6. PubMed ID: 11374737
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab-induced palmoplantar pustulosis in a patient with crohn disease.
    Sladden MJ, Clarke PJ, Wettenhall J.
    Arch Dermatol; 2007 Nov 11; 143(11):1449. PubMed ID: 18025378
    [No Abstract] [Full Text] [Related]

  • 18. Infliximab-induced acne: report of a third case.
    Sladden MJ, Clarke PJ, Mitchell B.
    Br J Dermatol; 2008 Jan 11; 158(1):172. PubMed ID: 17854357
    [No Abstract] [Full Text] [Related]

  • 19. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
    Ben Hriz F, Habbessi H, Maamouri N, Belkahla N, Ouerdiane S, Chouaib S, Ouerghi H, Chaabouni H, Ben Mami N.
    Tunis Med; 2009 Aug 11; 87(8):545-6. PubMed ID: 20180364
    [No Abstract] [Full Text] [Related]

  • 20. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.
    Thayu M, Markowitz JE, Mamula P, Russo PA, Muinos WI, Baldassano RN.
    J Pediatr Gastroenterol Nutr; 2005 Feb 11; 40(2):220-2. PubMed ID: 15699701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.